METHOD FOR TREATING DISEASES USING HSP90-INHIBITING AGENTS IN COMBINATION WITH ANTIMITOTICS
    1.
    发明授权
    METHOD FOR TREATING DISEASES USING HSP90-INHIBITING AGENTS IN COMBINATION WITH ANTIMITOTICS 有权
    方法与HSP90消炎药疾病杂志与抗有丝分裂结合物处理

    公开(公告)号:EP1628667B1

    公开(公告)日:2009-07-29

    申请号:EP04753672.7

    申请日:2004-05-28

    IPC分类号: A61K45/06

    CPC分类号: A61K45/06 A61K31/427

    摘要: The present invention provides a method for treating cancer. The method involves the administration of an HSP90 inhibitor and an antimitotic, where the combined administration provides a synergistic effect. In one aspect of the invention, a method of treating cancer is provided where a subject is treated with a dose of an HSP90 inhibitor in one step and a dose of an antimitotic in another step. In another aspect of the invention, a method of treating cancer is provided where a subject is first treated with a dose of an HSP90 inhibitor and subsequently treated with a dose of an antimitotic. In another aspect of the invention, a method of treating cancer is provided where a subject is first treated with a dose of an antimitotic and subsequently treated with a dose of an HSP90 inhibitor.

    METHOD FOR TREATING DISEASES USING HSP90-INHIBITING AGENTS IN COMBINATION WITH ANTIMETABOLITES
    2.
    发明授权
    METHOD FOR TREATING DISEASES USING HSP90-INHIBITING AGENTS IN COMBINATION WITH ANTIMETABOLITES 有权
    方法与HSP90消炎药疾病的联合抗代谢物治疗

    公开(公告)号:EP1631267B1

    公开(公告)日:2008-01-02

    申请号:EP04776158.0

    申请日:2004-05-28

    IPC分类号: A61K31/33 A61K31/505

    摘要: The present invention provides a method for treating cancer. The method involves the administration of an HSP90 inhibitor and an antimetabolite, where the combined administration provides a synergistic effect. In one aspect of the invention, a method of treating cancer is provided where a subject is treated with a dose of an HSP90 inhibitor in one step and a dose of an antimetabolite in another step. In another aspect of the invention, a method of treating cancer is provided where a subject is first treated with a dose of an HSP90 inhibitor and subsequently treated with a dose of an antimetabolite. In another aspect of the invention, a method of treating cancer is provided where a subject is first treated with a dose of an antimetabolite and subsequently treated with a dose of an HSP90 inhibitor.

    METHOD FOR TREATING DISEASES USING HSP90-INHIBITING AGENTS IN COMBINATION WITH ANTIMITOTICS
    3.
    发明公开
    METHOD FOR TREATING DISEASES USING HSP90-INHIBITING AGENTS IN COMBINATION WITH ANTIMITOTICS 有权
    方法与HSP90消炎药疾病杂志与抗有丝分裂结合物处理

    公开(公告)号:EP1628667A1

    公开(公告)日:2006-03-01

    申请号:EP04753672.7

    申请日:2004-05-28

    IPC分类号: A61K31/535

    CPC分类号: A61K45/06 A61K31/427

    摘要: The present invention provides a method for treating cancer. The method involves the administration of an HSP90 inhibitor and an antimitotic, where the combined administration provides a synergistic effect. In one aspect of the invention, a method of treating cancer is provided where a subject is treated with a dose of an HSP90 inhibitor in one step and a dose of an antimitotic in another step. In another aspect of the invention, a method of treating cancer is provided where a subject is first treated with a dose of an HSP90 inhibitor and subsequently treated with a dose of an antimitotic. In another aspect of the invention, a method of treating cancer is provided where a subject is first treated with a dose of an antimitotic and subsequently treated with a dose of an HSP90 inhibitor.

    METHOD FOR TREATING DISEASES USING HSP90-INHIBITING AGENTS IN COMBINATION WITH ENZYME INHIBITORS
    4.
    发明公开
    METHOD FOR TREATING DISEASES USING HSP90-INHIBITING AGENTS IN COMBINATION WITH ENZYME INHIBITORS 审中-公开
    方法与HSP90消炎药疾病的结合酶抑制剂治疗

    公开(公告)号:EP1628623A2

    公开(公告)日:2006-03-01

    申请号:EP04753673.5

    申请日:2004-05-28

    IPC分类号: A61K6/00

    摘要: The present invention provides a method for treating cancer. The method involves the administration of an HSP90 inhibitor and an enzyme inhibitor, where the combined administration provides a synergistic effect. In one aspect of the invention, a method of treating cancer is provided where a subject is treated with a dose of an HSP90 inhibitor in one step and a dose of an enzyme inhibitor in another step. In another aspect of the invention, a method of treating cancer is provided where a subject is first treated with a dose of an HSP90 inhibitor and subsequently treated with a dose of an enzyme inhibitor. In another aspect of the invention, a method of treating cancer is provided where a subject is first treated with a dose of an enzyme inhibitor and subsequently treated with a dose of an HSP90 inhibitor.

    METHOD FOR TREATING DISEASES USING HSP90-INHIBITING AGENTS IN COMBINATION WITH ANTIMETABOLITES
    5.
    发明公开
    METHOD FOR TREATING DISEASES USING HSP90-INHIBITING AGENTS IN COMBINATION WITH ANTIMETABOLITES 有权
    方法与HSP90消炎药疾病的联合抗代谢物治疗

    公开(公告)号:EP1631267A2

    公开(公告)日:2006-03-08

    申请号:EP04776158.0

    申请日:2004-05-28

    IPC分类号: A61K31/00

    摘要: The present invention provides a method for treating cancer. The method involves the administration of an HSP90 inhibitor and an antimetabolite, where the combined administration provides a synergistic effect. In one aspect of the invention, a method of treating cancer is provided where a subject is treated with a dose of an HSP90 inhibitor in one step and a dose of an antimetabolite in another step. In another aspect of the invention, a method of treating cancer is provided where a subject is first treated with a dose of an HSP90 inhibitor and subsequently treated with a dose of an antimetabolite. In another aspect of the invention, a method of treating cancer is provided where a subject is first treated with a dose of an antimetabolite and subsequently treated with a dose of an HSP90 inhibitor.

    METHOD FOR TREATING DISEASES USING HSP90-INHIBITING AGENTS IN COMBINATION WITH PLATINUM COORDINATION COMPLEXES
    6.
    发明公开
    METHOD FOR TREATING DISEASES USING HSP90-INHIBITING AGENTS IN COMBINATION WITH PLATINUM COORDINATION COMPLEXES 审中-公开
    17烷基氨基-17- desmethoxygeldanamycin和奥沙利铂在乳腺癌和结肠直肠癌的治疗中的用途

    公开(公告)号:EP1628657A2

    公开(公告)日:2006-03-01

    申请号:EP04753658.6

    申请日:2004-05-28

    IPC分类号: A61K31/33 A61K31/28

    摘要: The present invention provides a method for treating cancer. The method involves the administration of an HSP90 inhibitor and a platinum coordination complex, where the combined administration provides a synergistic effect. In one aspect of the invention, a method of treating cancer is provided where a subject is treated with a dose of an HSP90 inhibitor in one step and a dose of a platinum coordination complex in another step. In another aspect of the invention, a method of treating cancer is provided where a subject is first treated with a dose of an HSP90 inhibitor and subsequently treated with a dose of a platinum coordination complex. In another aspect of the invention, a method of treating cancer is provided where a subject is first treated with a dose of a platinum coordination complex and subsequently treated with a dose of an HSP90 inhibitor.